Looks like this $5.1m could be CLI partner upfront after presentation today we have started planning a phase 2 trial.
Trial set up H2 2018
Recruit H1 2019
It's a bigger market opportunity than GvHD by 4-5x
This is where the business model really starts to throw out huge numbers.
So GvHD is worth potentially $40m pa, and it's a royalty model.
say 50% falls to bottom line when in commercial production.
PE 20x (SaaS model)
GvHD value $400m
Also add the recent CTM Foot Ulcer JV likely to go to Phase 2, and I believe this would be a seperate target to CLI
now you can start to see how the cap can build with multiple targets next 2-5 years
- Forums
- ASX - By Stock
- CYP
- Shaw and Partners Research Update
Shaw and Partners Research Update, page-7
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
19.0¢ |
Change
0.010(5.56%) |
Mkt cap ! $34.32M |
Open | High | Low | Value | Volume |
18.0¢ | 19.5¢ | 18.0¢ | $9.062K | 48.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 104632 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 3 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4632 | 0.185 |
4 | 66488 | 0.180 |
1 | 285 | 0.175 |
2 | 4148 | 0.170 |
2 | 25050 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 3 | 1 |
0.195 | 38853 | 1 |
0.200 | 25789 | 2 |
0.210 | 60000 | 1 |
0.250 | 16097 | 2 |
Last trade - 14.37pm 12/09/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |